GB2000138B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB2000138B
GB2000138B GB7826308A GB7826308A GB2000138B GB 2000138 B GB2000138 B GB 2000138B GB 7826308 A GB7826308 A GB 7826308A GB 7826308 A GB7826308 A GB 7826308A GB 2000138 B GB2000138 B GB 2000138B
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7826308A
Other languages
English (en)
Other versions
GB2000138A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2000138(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB2000138A publication Critical patent/GB2000138A/en
Application granted granted Critical
Publication of GB2000138B publication Critical patent/GB2000138B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB7826308A 1977-06-07 1978-06-02 Therapeutic agents Expired GB2000138B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (2)

Publication Number Publication Date
GB2000138A GB2000138A (en) 1979-01-04
GB2000138B true GB2000138B (en) 1982-03-03

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7826308A Expired GB2000138B (en) 1977-06-07 1978-06-02 Therapeutic agents

Country Status (35)

Country Link
AR (1) AR224111A1 (de)
AT (2) AT360649B (de)
AU (1) AU513636B2 (de)
BE (1) BE867859A (de)
BG (2) BG34615A3 (de)
CH (1) CH634073A5 (de)
CS (1) CS208472B2 (de)
DD (2) DD140888A5 (de)
DE (2) DE2857263C3 (de)
DK (1) DK155740C (de)
EG (1) EG13869A (de)
FI (1) FI66003C (de)
FR (2) FR2393804A1 (de)
GB (1) GB2000138B (de)
GR (1) GR72255B (de)
HK (1) HK13184A (de)
HU (1) HU180042B (de)
IE (1) IE47079B1 (de)
IL (2) IL54867A (de)
IN (1) IN149747B (de)
IT (1) IT1096381B (de)
KE (1) KE3355A (de)
LU (1) LU79774A1 (de)
MY (1) MY8500092A (de)
NL (2) NL180009C (de)
NO (2) NO151746C (de)
NZ (1) NZ187476A (de)
OA (1) OA05964A (de)
PH (3) PH26810A (de)
PL (1) PL114501B1 (de)
PT (1) PT68146A (de)
SE (2) SE436206B (de)
SG (1) SG65383G (de)
SU (1) SU860706A1 (de)
YU (1) YU41829B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (de) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (de) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (de) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Verfahren zur Herstellung von 6,6-Dibromopenicillansäure-1,1-Dioxyd
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
EP0262202B1 (de) * 1986-04-10 1992-07-01 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Verfahren zur herstellung von penicillansäure-derivaten
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (de) * 1977-05-09 1979-01-18
EP0000636A1 (de) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, sowie die Azetidinone gebraucht für ihre Herstellung

Also Published As

Publication number Publication date
IE781140L (en) 1978-12-07
AT360649B (de) 1981-01-26
EG13869A (en) 1983-03-31
DD148585A5 (de) 1981-06-03
AT364084B (de) 1981-09-25
SE8305916L (sv) 1983-10-27
IL54867A0 (en) 1978-08-31
PH26810A (en) 1992-11-05
SG65383G (en) 1985-03-29
SE447995B (sv) 1987-01-12
NL180009C (nl) 1986-12-16
AR224111A1 (es) 1981-10-30
CS208472B2 (en) 1981-09-15
NZ187476A (en) 1982-08-17
BG34614A3 (en) 1983-10-15
BG34615A3 (en) 1983-10-15
DE2824535B2 (de) 1980-05-14
OA05964A (fr) 1981-06-30
FR2393804A1 (fr) 1979-01-05
SE436206B (sv) 1984-11-19
YU41829B (en) 1988-02-29
KE3355A (en) 1983-12-16
NO823126L (no) 1978-12-08
DK155740B (da) 1989-05-08
PH16465A (en) 1983-10-20
PH21116A (en) 1987-07-16
FI781800A (fi) 1978-12-08
NO151746B (no) 1985-02-18
DE2824535A1 (de) 1978-12-14
FR2393805B1 (de) 1984-02-24
YU117078A (en) 1983-01-21
LU79774A1 (fr) 1980-01-22
BE867859A (fr) 1978-12-06
DK155740C (da) 1989-10-23
IT7824270A0 (it) 1978-06-06
ATA411278A (de) 1980-06-15
NO151746C (no) 1985-06-05
CH634073A5 (en) 1983-01-14
IT1096381B (it) 1985-08-26
DE2857263B2 (de) 1981-04-23
IL54867A (en) 1981-11-30
GR72255B (de) 1983-10-06
DE2824535C3 (de) 1981-01-22
NO781970L (no) 1978-12-08
NL930064I2 (nl) 1994-04-18
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
NO152448B (no) 1985-06-24
HK13184A (en) 1984-02-24
PL114501B1 (en) 1981-02-28
NO152448C (no) 1985-10-02
NL930064I1 (nl) 1993-09-01
DE2857263C3 (de) 1981-12-17
HU180042B (en) 1983-01-28
AU3683878A (en) 1979-12-06
DD140888A5 (de) 1980-04-02
PT68146A (en) 1978-07-01
MY8500092A (en) 1985-12-31
IL62168A0 (en) 1981-03-31
SE7806628L (sv) 1978-12-08
FI66003B (fi) 1984-04-30
SE8305916D0 (sv) 1983-10-27
AU513636B2 (en) 1980-12-11
IE47079B1 (en) 1983-12-14
FR2393804B1 (de) 1980-11-07
PL207396A1 (pl) 1979-06-04
FI66003C (fi) 1984-08-10
IN149747B (de) 1982-04-03
ATA128580A (de) 1981-02-15
NL7806126A (nl) 1978-12-11
GB2000138A (en) 1979-01-04
SU860706A1 (ru) 1981-08-30

Similar Documents

Publication Publication Date Title
GB2000136B (en) Therapeutic agents
GB2005248B (en) Therapeutic agents
ZA782816B (en) Therapeutic agents
GB2000138B (en) Therapeutic agents
ZA782919B (en) Hydantoin therapeutic agents
ZA801328B (en) Therapeutic agents
GB2000131B (en) Therapeutic agents
ZA80298B (en) Therapeutic agents
AU507028B2 (en) Therapeutic agents
EG16606A (en) Therapeutic agents
ZA78413B (en) New therapeutic agents
GB2004876B (en) Therapeutic agents
GB2007656B (en) Therapeutic agents
ZA786184B (en) Therapeutic agents
PH14956A (en) Trans-broparestrol based therapeutic
ZA77776B (en) Therapeutic agents
ZA786259B (en) Therapeutic composition
ZA78554B (en) Novel therapeutic agents
GB2000510B (en) Therapeutic agents
GB2010824B (en) Therapeutic agents
GB2047691B (en) Therapeutic agents
GB2053910B (en) Pyridylaminotriazole therapeutic agents
JPS53117285A (en) Massager
GB2007654B (en) Therapeutic agents
GB2008104B (en) Therapeutic agents

Legal Events

Date Code Title Description
CTFF Supplementary protection certificate filed

Free format text: SPC/GB93/049, 930525

CTFG Supplementary protection certificate granted

Free format text: SPC/GB93/049, 931110, EXPIRES:20000826

CTFE Supplementary protection certificate entered into force

Free format text: SPC/GB93/049, 980602, EXPIRES: 20000826

PE20 Patent expired after termination of 20 years

Effective date: 19980601

SPCE Supplementary protection certificate expired

Free format text: SPC/GB93/049, 20000826